The Law Firm of Weiss & Lurie Investigates the Proposed Buyout of Caraco Pharmaceuticals Laboratories Ltd.
09 December 2010 - 8:13AM
Business Wire
Weiss & Lurie, a national class action and shareholder
rights law firm with offices in New York City and Los Angeles, is
investigating potential claims against members of the Board of
Directors of Caraco Pharmaceuticals Laboratories Ltd. (AMEX: CPD),
Sun Pharmaceuticals Laboratories Ltd. and Sun Pharma Global, Inc.
(“Sun Pharma”), arising from Caraco’s receipt of a proposal by Sun
Pharma and/or one or more of their affiliates to acquire the
remainder of Caraco shares not already owned by Sun Pharma, in a
potential transaction offering Caraco public shareholders $4.75 in
cash for each share of Caraco stock they hold. In response to the
proposal, Caraco shares closed at $5.13 per share on December 6,
2010. Caraco shares were trading as high as $6.66 as of August 9,
2010.
Weiss & Lurie is investigating whether Caraco’s Board is
acting in the best interests of its public shareholders in seeking
to maximize shareholder value by adequately shopping Caraco and
whether the sales process is unfair to Caraco public shareholders
in light of the fact that Sun Pharma already owns approximately
75.8% of Caraco’s outstanding shares.
If you own common stock in Caraco and would like more
information about your rights as a shareholder or additional
information concerning our investigation, please contact Michael A.
Rogovin either by email at infony@weisslurie.com or by telephone at
(888) 593-4771. Weiss & Lurie has litigated hundreds of
stockholder class and derivative actions for violations of
corporate and fiduciary duties. We have recovered over a billion
dollars for defrauded institutions and individuals and obtained
important corporate governance in these cases. If you have
information or would like legal advice concerning possible
corporate wrongdoing (such as insider trading, waste of corporate
assets, accounting fraud, or issuing materially misleading press
releases or SEC filings), consumer fraud (such as false
advertising, defective products, or other deceptive business
practices), or anti-trust violations, please email us at
infony@weisslurie.com or fill out the form on our website,
http://www.weisslurie.com/contact/report_fraud/.
Attorney Advertising. Past results do not guarantee a similar
outcome.
Caraco (AMEX:CPD)
Historical Stock Chart
From Oct 2024 to Nov 2024
Caraco (AMEX:CPD)
Historical Stock Chart
From Nov 2023 to Nov 2024
Real-Time news about Caraco Pharmaceutical Laboratories, Ltd. Common Stock (American Stock Exchange): 0 recent articles
More Weiss & Lurie News Articles